Related Experiment Video
Updated: Dec 19, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation
Yong Chi1,2, John H Carter3, Jherek Swanger1
1Divisions of Clinical Research and Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N. Seattle, WA 98109, USA.
Abstract:
Cyclin-dependent kinase 2 (CDK2) controls cell division and is central to oncogenic signaling. We used an "in situ" approach to identify CDK2 substrates within nuclei isolated from cells expressing CDK2 engineered to use adenosine 5'-triphosphate analogs. We identified 117 candidate substrates, ~40% of which are known CDK substrates. Previously unknown candidates were validated to be CDK2 substrates, including LSD1, DOT1L, and Rad54. The identification of many chromatin-associated proteins may have been facilitated by labeling conditions that preserved nuclear architecture and physiologic CDK2 regulation by endogenous cyclins. Candidate substrates include proteins that regulate histone modifications, chromatin, transcription, and RNA/DNA metabolism. Many of these proteins also coexist in multi-protein complexes, including epigenetic regulators, that may provide new links between cell division and other cellular processes mediated by CDK2. In situ phosphorylation thus revealed candidate substrates with a high validation rate and should be readily applicable to other nuclear kinases.
Insights
Researchers identified 117 potential cell division targets of cyclin-dependent kinase 2 (CDK2) using an in situ method. This approach revealed new CDK2 substrates involved in chromatin regulation and epigenetic processes.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin-dependent kinase 2 (CDK2) plays a critical role in regulating the cell cycle.
- CDK2 is implicated in various cancers due to its central role in oncogenic signaling pathways.
Purpose of the Study:
- To identify novel substrates of CDK2 within the cell nucleus using an "in situ" approach.
- To investigate the role of CDK2 in regulating chromatin, transcription, and DNA/RNA metabolism.
Main Methods:
- Utilized an "in situ" phosphorylation method on isolated nuclei from cells engineered to express a modified CDK2.
- Employed adenosine 5 omino-triphosphate analogs for specific labeling of CDK2 substrates.
- Validated candidate substrates through biochemical assays.
Main Results:
- Identified 117 candidate CDK2 substrates, with approximately 40% being previously known.
- Validated novel substrates, including LSD1, DOT1L, and Rad54, demonstrating CDK2's involvement in epigenetic regulation.
- Discovered that many identified substrates are chromatin-associated proteins involved in histone modification, transcription, and nucleic acid metabolism.
Conclusions:
- The "in situ" phosphorylation technique is effective for identifying nuclear kinase substrates with high validation rates.
- CDK2 substrates are involved in diverse cellular processes, including epigenetic regulation and nucleic acid metabolism, suggesting new links between cell division and these functions.
- This methodology can be broadly applied to discover substrates for other nuclear kinases.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases

